Take a listen about what I learned during Boston Biotech Week and the RESI conference. itunes.apple.com/us/podcast/life-sciences-rush-hour-investing-news-risk-management/id1384888594
Yesterday was dominated by Biogen's news on their Alzheimer drug, but there was other news including Sarepta getting slapped with a clincial hold, Gilead CEO stepping down and, although not Life Science related, Facebook getting crushed after their earnings. Here is what I'm reading: Yesterday afternoon Eisai & Biogen Revealed Promising Alzheimer’s Data But Questions … Continue reading Thursday Morning Headlines
Good morning and happy Tuesday. Here is what I am reading this morning: How United Technologies wants to use 3-D-printed lungs to end transplant shortages (MIT Technology Review). T cell 'backpacks' boost immune attack against solid tumors in mice. These nanoparticle backpacks would attach to T cells and hopefully make it easier to translate to … Continue reading Tuesday Morning Reads
Good morning, here is what I am reading this morning. I was compelled to include the first article as I am proud that my Alma mater is investing in the biotech space and having the companies they invest in commit to staying in Philadelphia. Penn invests ‘several million’ in Carisma Therapeutics as part of $50M … Continue reading Thursday Morning Reads
We are finally at the end of the work week and this is what I am reading in the home stretch: Hot to not: The valuation implosion at Theranos A Biotech Executive Faces End-Stage Cancer As A Patient – Definitely worth watching the embedded video included with the story. For smaller companies, a presence at … Continue reading Friday Reads
For companies just starting out or at Seed stage, insurance is usually something that is not thought about until someone you are doing business with asks for evidence of your insurance program. At that point it means the insurance was usually already required as part of a lease, a contract, a statutory requirement or a … Continue reading I’m a Startup and Need Insurance…Now!
Wednesday reads to get your day going the right way. The (new) top 10 pharma companies by 2017 revenue Will New Study Cut Guesswork for Depression Medicine Prescriptions? Banks scramble to assemble Asian biotech IPO resources. Institutions aim to capitalize on a listings boom but lack expertise in the region. A stealthy Harvard startup wants … Continue reading What I’m Reading Today